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MembraneThe cortical cytoskeleton constitutes an important subcellular structure that determines cell shape and regulates
cell migration as well as membrane trafﬁc to and from the plasmamembrane. Many components of the cortical
cytoskeleton have been identiﬁed including structural and scaffolding proteins, membrane–cytoskeleton linker
proteins and signaling intermediates. We describe here an association of the membrane-F-actin linker protein
ezrin with the scaffolding protein IQGAP1 that serves as a hub for concentrating different signaling complexes.
Both, ezrin and IQGAP1 bind in a Ca2+-dependent manner to the EF hand protein S100P and complexes
consisting of Ca2+-bound S100P, IQGAP1 and ezrin can be isolated by immunoprecipitation. Ezrin and IQGAP1
also interact in the absence of Ca2+, thus independent of S100P. Direct ezrin–IQGAP1 interaction can be shown
with the puriﬁed proteins. It is mediated via the N-terminal FERM domain of ezrin and the IQ domain of
IQGAP1, respectively. Ezrin and IQGAP1 colocalize in the submembraneous cytoskeleton and in cellular protru-
sions of human epithelial cells and knockdown of ezrin reduces the cortical localization of IQGAP1. Thus, ezrin
appears to participate in recruiting IQGAP1 to the cell cortex thereby establishing a close connection between
membrane-F-actin contacts and actin regulators that can be assembled by IQGAP1. This article is part of a Special
Issue entitled: 13th European Symposium on Calcium.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Fundamental cellular processes such as differentiation, cell shape
control, migration and intracellular trafﬁcking require an active contri-
bution of the cortical membrane-underlying cytoskeleton, a subcellular
structure rich in actin ﬁlaments. Many components of the submem-
braneous cytoskeleton that interact with F-actin in a direct or indirect
manner have been described and shown to play a role in conferring
structural stability, membrane linkage and regulation of actin ﬁlament
polymerization, branching and contractility (for review see [1]). These
components include different myosins, actin bundling and crosslinking
proteins, proteins that link actin ﬁlaments to the plasmamembrane and
regulators of actin polymerization and ﬁlament architecture, most
prominently small GTPases of the Rho family and their downstream tar-
gets. Interactions between different components of the cortical cyto-
skeleton are manyfold, thereby enabling the assembly of a network
structure that is highly ﬂexible and can function both, as rigid scaffold
in stable membrane extensions such as microvilli and stereocilia andopean Symposium on Calcium.
emistry, Centre for Molecular
march-Str. 56, 48149 Münster,as highly dynamic interface in ﬁlopodia, lamellipodia and membrane
blebs that form in the course of cell migration (for recent reviews see
[2–6]). However, although components of the cortical cytoskeleton
have been studied extensively, the regulation of their assembly and dis-
assembly is still not fully understood.
Ca2+ is an important signal known to trigger changes in the assem-
bly and rigidity of the cell cortex [7] and several proteins transmitting
transient Ca2+ elevations to downstream targets in the cortical cyto-
skeleton have been described. One class of Ca2+ binding proteins
involved in this transduction of Ca2+ signals in the cell cortex is the
S100 proteins, members of the EF hand superfamily. S100 proteins con-
sist of two EF hand Ca2+-binding motifs that are connected by a short
linker and ﬂanked by N- and C-terminal extensions of different length
and sequence. As a general paradigm, S100 proteins transmit Ca2+
signals by interacting with and regulating speciﬁc effectors in their
Ca2+ bound conformation and these effectors are thought to confer
speciﬁcity to the respective S100 protein action (for review see
[8–10]). S100P is a member of the family shown previously to bind
and regulate two important components of the cortical cytoskeleton,
ezrin and IQGAP1 [11]. Ezrin belongs to the ERM (ezrin–radixin–
moesin) family of proteins that link plasma membrane-resident
proteins to the cortical actin cytoskeleton. This linkage can occur via
direct binding of the N-terminal ERM association domain (N-ERMAD;
also called FERM for 4.1, ERM domain) to membrane proteins and the
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because ezrin and the other ERM proteins reside in an autoinhibited
conformation in non-stimulated cells (for review see [13]). Ca2+-
triggered binding of S100P to theN-ERMADcan relieve the autoinhibition
and thereby activate ezrin's function in, e.g. cell migration [15]. IQGAP1,
on the other hand, is a multidomain scaffolding protein of the cell cortex
that can recruit many interaction partners and thereby act in signal
transduction pathways and the regulation of actin cytoskeleton and mi-
crotubule dynamics (for reviews see [16,17]). S100P binding to IQGAP1,
which is also Ca2+ dependent, has been shown to alter signal transduc-
tion properties of IQGAP1, speciﬁcally the binding of B-Raf and activation
ofMEK1/2 occurring in response to EGF treatment [12]. Although IQGAP1
has not been shown to participate directly in physical membrane–
cytoskeleton linkage, it has been reported that it can associate with
FERMdomain containing proteins such as protein 4.1R [16,18].Moreover,
a proteomic approach employing the internal repeat region of IQGAP1 as
a bait recently identiﬁed ezrin, radixin andmoesin as interacting proteins
suggesting a link between IQGAP1 and ERM proteins [19].
A link between IQGAP1 and ezrin could also be established by
S100P that can interact directly with both, ezrin and IQGAP1. Therefore,
we herein investigated whether complexes consisting of S100P, ezrin
and/or IQGAP1 can exist in cells. Such complexes could provide a
means to physically connect ezrin's membrane-F-actin linking activity
with regulators of the actin cytoskeleton such as Cdc42, Rac1 and Dia1
that can be recruited by IQGAP1. We show that S100P, IQGAP1 and
ezrin can indeed be precipitated together from cell lysates in a Ca2+
dependent manner. Interestingly, upon extending our analyses to the
Ca2+ regulation of complex formation we observed that an interaction
between ezrin and IQGAP1 can also occur in the absence of Ca2+ and
S100P. This interaction is direct, is mediated by the N-ERMAD and IQ
domain of ezrin and IQGAP1, respectively, and is in line with a
colocalization of both proteins in the cortex of human epithelial cells.
Furthermore, siRNA-mediated depletion experiments reveal that ezrin
is required for an efﬁcient cortical localization of IQGAP1 in these cells.
Thus, our results identify a direct interaction between ezrin and the IQ
domain of IQGAP1 that could be of importance for connecting the
IQGAP1-mediated cortical assembly of actin regulators to the
membrane-F-actin linkage provided by ezrin.
2. Materials and methods
2.1. Cell culture and transfection
HeLa and HEK293T cells were maintained in Dulbecco's modiﬁed
Eagle's medium supplemented with 10% fetal calf serum (FCS), 2 mM
L-glutamine, and antibiotics in a 7% CO2 incubator at 37 °C. For EGF stim-
ulation experiments, HeLawere ﬁrst starved by cultivation in serum free
medium for 16 h. Subsequently, EGF was added to a ﬁnal concentration
of 50 ng/ml and cultivation was continued for the times indicated.
Human urinary bladder carcinoma (ECV304) cells were maintained in
Earle's 199 medium supplemented with 10% fetal calf serum (FCS),
2 mM L-glutamine, and antibiotics in a 5% CO2 incubator at 37 °C.
Spodoptera frugiperda 9 (SF9) insect cells were cultured in TC-100medi-
umwith 10% FCS and0.26% tryptose phosphate broth (Sigma) at 27 °C in
air atmosphere. Cells were transiently transfected using Lipofectamine
2000 (Invitrogen) according to the manufacturer's instructions unless
stated otherwise. Transient siRNA transfections to down-regulate ezrin
were performed using siGENOME SMART pool human ezrin siRNA
(Dharmacon). Transfections were performed using Lipofectamine-
2000 (Invitrogen) according to manufacturer's instructions.
2.2. Plasmids
pCantag-IQGAP1 full length and pCDNA3.1 plasmids encoding dif-
ferent domains of human IQGAP1 were generated as described [20].Constructs encoding His-tagged versions of the N-ERMAD and C-
ERMAD of human ezrin in pET-28a as well as the GFP–S100P plasmid
have been described previously [11].
2.3. Recombinant protein expression and puriﬁcation
Expression and puriﬁcation of full length GST–IQGAP1 from SF9
insect cells infected with Autographa californica nuclear polyhedrosis
baculoviruses was performed as described [12]. GST-tagged N-ERMAD,
(His)6-tagged S100P was puriﬁed from Escherichia coli cells (strain
BL21(DE3)pLysS) as described earlier [12].
(His)6-tagged N- or C-ERMAD was expressed in E. coli cells (strain
BL21(DE3)pLysS). Transformed bacteria were grown to an OD600 of
0.6 at 37 °C, and recombinant protein expression was then induced
by adding isopropyl β-D-1-thiogalactopyranoside to a ﬁnal concentra-
tion of 1 mM. After incubation for 3 h at 37 °C, cells were harvested by
centrifugation (2500 ×g; 10 min) and resuspended in lysis buffer
(40 mM Hepes, pH 7.4, 20 mM imidazole, pH 7.4, 300 mM NaCl, 1 mM
EDTA, 10 mM β-mercaptoethanol, 1 mM PMSF). Cells were lysed by
three freeze/thaw cycles and sonication (duty cycle 50%, output control
5′), and the remaining cellular debriswas removed by centrifugation for
1 h at 100,000 ×g. The supernatant obtained after the ultracentrifuga-
tion step was applied to a Ni–NTA-agarose column equilibrated with
lysis buffer. After washing with washing buffer (40 mM Hepes, pH 7.4,
150 mM NaCl, 10 mM β-mercaptoethanol, 1 mM PMSF) containing in-
creasing concentrations of imidazole (25 and 35 mM), His-tagged-N-
or C-ERMAD was eluted with this buffer supplemented with 250 mM
imidazole.
2.4. In vitro transcription/translation
[35S]-methionine labeled IQGAP1 full length and domains were
expressed using the TnT® Quick-coupled transcription/translation
system (Promega, Madison, WI). 50 μL reaction mixture contained
1 μg of pCDNA construct encoding the respective IQGAP1 derivative
(full-length or mutant), 9 μCi of [35S] methionine (GE-Healthcare) and
40 μL of TnT® Quick Master Mix. This mixture was incubated at 30 °C
for 90 min. 10% of the mixture was subjected to SDS-PAGE and autora-
diography to conﬁrm the proper translation and labeling and the re-
maining 45 μL was used in the in vitro interaction assays.
2.5. In vitro interaction assays
In vitro binding assays were performed using a column-based afﬁn-
ity chromatography approach. To analyze the interaction of IQGAP1 and
ezrin, glutathione-Sepharose 4B (GE Healthcare) beads containing 3 μg
of immobilized GST–IQGAP1 or GST alone as control were equilibrated
in buffer A (40 mM Hepes, pH 7.4, 20 mM imidazole, pH 7.4, 150 mM
NaCl, 1 mM DTT, 1.5 mM PMSF). 30 μg of His-tagged N- or C-ERMAD
protein was dialyzed against the equilibration buffer and added in
the ﬂuid phase. After incubation at 4 °C for 1 h and washing with the
same buffer, the protein complexes were eluted with 40 mM Hepes,
pH 7.4, and 100 mMGSH. Fractions of the ﬂow-through and of washing
and elution steps were collected and analyzed by SDS-PAGE and
Western blots employing monoclonal mouse anti-GST (B14, Santa
Cruz Biotechnology, Heidelberg, Germany) and monoclonal mouse
anti-His antibodies (Qiagen, Hilden, Germany) followed by a goat
anti-mouse POX labeled secondary antibodies (Dianova, Hamburg,
Germany).
For further mapping of the N-ERMAD binding domain on IQGAP1,
equivalent amounts of puriﬁed GST-tagged N-ERMAD and GST
alone (control) were immobilized to glutathione-Sepharose 4B (GE
Healthcare) beads in buffer A. A small aliquot of protein-immobilized
resin was subjected to SDS-PAGE and stained with Coomassie Brilliant
Blue or probed by immunoblotting to ensure that equal amounts of pro-
teins were used. In vitro translated, [35S]-methionine-labeled IQGAP1
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Fig. 1. Pulldown of ezrin and IQGAP1 by S100P. 3 mg of protein from a post nuclear super-
natant (PNS) of HeLa cells lysed in the presence of 0.5 mM CaCl2 or 10 μM ZnSO4 was ap-
plied toNi–NTA agarose containing immobilized 5 μg S100Pwildtype (WT). Afterwashing
with lysis buffer containing either Ca2+ or Zn2+, the remaining column-bound protein
complexes and the PNS were subjected to Western blot analysis using monoclonal anti-
IQGAP1 (dilution 1:5000) and polyclonal anti-ezrin (1:5000) antibodies. Lanes 2 and 4
depict control experiments employing Ni–NTA agarose beads alone. The blot shows a rep-
resentative example of 3 independent experiments.
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and incubated overnight at 4 °C. Afterwashingwith the respective bind-
ing buffers, bound proteins were eluted with boiling SDS sample buffer
and analyzed by SDS-PAGE and autoradiography.
2.6. Co-immunoprecipitation and pulldown experiments
Control or GFP–S100P overexpressing HeLa cells of a 100 mm
culture dish were washed once with PBS and scraped into 0.5 ml
of lysis buffer (20 mM imidazole, pH 6.8, 100 mM NaCl, 1% Triton-X-
100, 0.04% NaN3 and Complete protease inhibitor mixture (Roche Diag-
nostics)) containing either 0.5 mM CaCl2 or 2 mM EGTA. Cell lysis was
performed on an overhead shaker for 30min at 4 °C followed by centri-
fugation (300 ×g, 30 min, 4 °C). 3 mg of total protein of the resultant
post-nuclear supernatant (PNS) was applied to protein A-Sepharose
Cl-4B (GE Healthcare) equilibrated in lysis buffer either together with
a polyclonal rabbit anti-IQGAP1 antibody (H-108, Santa Cruz Biotech-
nology) or nonspeciﬁc polyclonal rabbit IgGs (DAKO, Glostrup,
Denmark). After incubation for 2 h or overnight at 4 °C and washing
with the respective lysis buffer, boundproteinswere elutedwith boiling
SDS sample buffer. Samples of the PNS and the eluted proteinswere an-
alyzed by SDS-PAGE and Western blot using monoclonal anti-IQGAP1
antibodies diluted 1:5000 (BD Biosciences) and polyclonal rabbit anti-
ezrin antibodies diluted 1:5000 (Upstate Biotechnology, Inc., Lake
Placid, NW) or monoclonal mouse anti-ezrin antibodies diluted 1:250
(BD Transduction laboratories, Heidelberg, Germany) followed by
the respective POX-labeled secondary antibodies or infrared-labeled
Odyssey® secondary antibodies (LI-COR Biosciences, Germany).
Relative amounts of ezrin co-immunoprecipitated with IQGAP1 in
Ca2+ and EGTA conditions were quantiﬁed in relation to the precipitat-
ed IQGAP1 by densitometry using ImageJ. For this purpose, amounts of
co-precipitated ezrin from three independent co-IP experiments were
compared to the corresponding amount of IQGAP1.
2.7. Pulldown of ezrin and IQGAP1 from HeLa lysates using puriﬁed S100P
Pulldown experiments of His-tagged S100P wild type with endoge-
nous ezrin and IQGAP1 fromHeLa cell lysates employed 5 μg of puriﬁed
S100P wild type protein that was immobilized to Ni–NTA-agarose
(Macherey Nagel, Germany) beads. HeLa cells grown on a 100 mm cul-
ture dish were scraped into lysis buffer (10 mMHepes, pH 7.4, 150mM
NaCl, 1% Triton X-100, 2 mM HEDTA, and Complete protease inhibitor
mixture (Roche Diagnostics)) containing either 500 μM CaCl2 or
10 μM ZnSO4. Lysis was performed on an overhead shaker for 30 min
at 4 °C followed by centrifugation (300 ×g, 30 min, 4 °C). 3 mg of total
protein from the resulting supernatant (PNS) was then applied to
immobilized S100P. After incubation on an overhead shaker overnight
at 4 °C and washing with lysis buffer, bound proteins were eluted
with boiling SDS sample buffer. Samples of the PNS and the eluted pro-
teins were analyzed by SDS-PAGE and Western blot using monoclonal
mouse anti-IQGAP1 antibodies diluted 1:5000 (BD Biosciences), poly-
clonal rabbit anti-ezrin antibodies diluted 1:5000 (Upstate Biotechnolo-
gy, Inc., Lake Placid, NW) and monoclonal mouse anti-6×His epitope
antibodies diluted 1:100 (Thermo Scientiﬁc) followed by the respective
infrared-labeled Odyssey® secondary antibodies (LI-COR Biosciences,
Germany).
2.8. Immunoﬂuorescence analysis
Cells grown on ﬁbronectin-coated coverslips were ﬁxed with 3%
formaldehyde in PBS for 6 min at room temperature. Cells were then
subjected to permeabilization with 0.5% Triton-X-100 for 15 min and
quenching with NH4Cl for 15 min. Following treatment with 2% BSA in
PBS for 1 h, cells were incubatedwith rabbit polyclonal anti-IQGAP1 an-
tibodies diluted 1:1000 (Santa Cruz Biotechnology) and mouse mono-
clonal anti-ezrin antibodies diluted 1:100 (clone 18, BD biosciences)overnight at 4 °C. Primary antibodies were detected with Alexa Fluor
488 goat anti-rabbit (diluted 1:400) (Invitrogen) and Alexa Fluor 568
donkey anti-mouse diluted (1:200) (Invitrogen) secondary antibodies.
Stained cells were mounted in Mowiol and analyzed using a confocal
laser scanning microscope (LSM 780; Zeiss, Jena, Germany).
2.9. Quantiﬁcation of cortical IQGAP1 staining
To quantify the levels of cortical IQGAP1 enrichment, control
and ezrin downregulated ECV304 cells were imaged using exactly the
same confocal laser scanning parameters. Cortical IQGAP1 enrichment
was quantiﬁed using ImageJ. Therefore, the raw integrated density of
IQGAP1 from a deﬁned cortical region was divided by the raw integrat-
ed density of total cellular IQGAP1. This yielded the percentage cortical
enrichment relative to the total cellular IQGAP1. The mean relative en-
richment in 30 control cells was then compared to themean relative en-
richment in the same number of ezrin depleted cells.
2.10. Statistical analysis
Unpaired, two-tailed Student's t test was applied to determine if the
mean relative cortical enrichment of IQGAP1 in ezrin downregulated
ECV304 cells was signiﬁcantly decreased as compared to that of control
transfected cells. P b 0.05 was considered as signiﬁcant.
3. Results and discussion
3.1. Identiﬁcation of S100P–IQGAP1–ezrin complexes
Our previous biochemical work identiﬁed S100P–ezrin and S100P–
IQGAP1 complexes that only form in the presence of Ca2+, i.e. require
the Ca2+-bound conformation of S100P [11,12]. In these complexes
the binding sites on S100P map to different regions. Whereas the C-
terminal extension encompassing residues 87 to 95 harbors the ezrin
binding site [15], residues 21–25 in theN-terminal EF hand are required
for IQGAP1 binding [12]. This suggests that S100P can simultaneously
bind to ezrin and IQGAP1 although such simultaneous complex forma-
tion had not been shown before. To address this we carried out
pulldown experiments with His-tagged S100P that was immobilized
on Ni–NTA beads and incubated with HeLa cell lysates containing
endogenous ezrin and IQGAP1. Fig. 1 reveals that S100P can pulldown
both ezrin and IQGAP1 from the lysates in the presence of Ca2+.
S100B, another member of the S100 protein family, had also been
shown to bind IQGAP1 and in this case the interaction was observed
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GFP-S100P transfected
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Fig. 2. Co-immunoprecipitation of ezrin and IQGAP1 in the presence of S100P. Untransfected or pEGFP–S100Pwt-transfectedHeLa cellswere lysed 24 h post transfection in the presence of
0.5mMCaCl2. 3mg of protein of a post nuclear supernatant (PNS) prepared from the lysateswas subjected to immunoprecipitation using 5 μg of polyclonal anti-IQGAP1 antibodies (IP) or
nonspeciﬁc polyclonal IgGs as control (C). The PNS and theprecipitatedproteinswere subjected to 12%SDS-PAGE andWestern blot analysiswas performedusingmonoclonal anti-IQGAP1
(1:5000), monoclonal anti-ezrin (1:250) and monoclonal anti-GFP (1:1000) antibodies. Blot shows a representative example of 3 independent experiments.
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fore, we also determined whether Zn2+ can trigger an interaction
between S100P and ezrin/IQGAP1 by performing the pulldowns in the
presence of Zn2+ instead of Ca2+. As shown in Fig. 1, a pulldown of
ezrin and IQGAP1 by S100P is also observed in the presence of Zn2+,
most likely because Ca2+ and Zn2+ binding to S100P both induce theIQGAP1 Ez
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Fig. 3. Colocalization of ezrin and IQGAP1 in HeLa cells. HeLa cells were serum-starved for 16 h a
ﬁxation and permeabilization, cells were stainedwith polyclonal antibodies against human IQGA
channel) followed by appropriate ﬂuorescently labeled secondary antibodies. The lower panelsinteraction-competent conformation. The divalent cations, Ca2+ and
Zn2+, are essential to establish the S100P interactions with ezrin and
IQGAP1 as no pulldown is observed in the presence of EGTA (not
shown). Because S100P can form heterodimers with S100A1 [21] and
S100B forms heterodimerswith S100A1 [22], we also analyzedwhether
S100B is present in the S100P pulldowns. However, wewere not able torin Merge
nd either kept unstimulated (A) or were stimulatedwith 50 ng/ml EGF for 5min (B). After
P1 (1:1000) (green channel) andmonoclonal antibodies against human ezrin (1:100) (red
show higher magniﬁcations of the boxed areas. Scale bars, 10 μm.
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presence of Ca2+ nor in the presence of Zn2+ (not shown). Collectively,
the pulldowns indicate that Ca2+ and Zn2+ can trigger interactions of
S100P with ezrin and IQGAP1 and that ezrin and IQGAP1 do not effec-
tively compete with one another for S100P binding. While this suggests
that S100P can simultaneously bind ezrin and IQGAP1, we cannot for-
mally exclude that our pulldown approach enriches independently
formed S100P/ezrin and S100P/IQGAP1 complexes.
Next, we employed co-immunoprecipitation (co-IP) experiments
to verify that S100P–IQGAP1–ezrin complex formation can also occur
within cells. Due to the lack of highly speciﬁc antibodies against S100P
these experiments were carried out with HeLa cells ectopically express-
ingGFP–S100P. As shown in Fig. 2, both ezrin andGFP–S100P can be co-
immunoprecipitated with anti-IQGAP1 antibodies in the presence of
Ca2+ indicative of intracellular interactions probably resembling a tri-
partite complex. Interestingly, control experiments revealed an efﬁcient
co-IP of IQGAP1 and ezrin also in non-transfected cells (Fig. 2). Immuno-
ﬂuorescence analysis was next employed to analyze whether IQGAP1
and ezrin also colocalize within cells. Therefore, HeLa cells were either
left unstimulated or stimulated with EGF to raise intracellular Ca2+
levels and then ﬁxed and stained with anti-IQGAP1 and anti-ezrin anti-
bodies. Whereas both proteins show some general cytoplasmic distri-
bution, a signiﬁcant enrichment is seen at sites close to the plasmaA
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Fig. 4. Ezrin and IQGAP1 interact independently of Ca2+-S100P. A. HeLa cells were lysed in the p
(PNS) prepared from these lysateswere subjected to immunoprecipitation using 5 μg of polyclo
precipitated proteinswere analyzed byWestern blot usingmonoclonal anti-IQGAP1 (1:5000) a
the co-IP carried out in 0.5 mM CaCl2 and 2mM EGTA was compared to the corresponding amo
andmethods. B. HeLa cells were serum starved for 16 h and either kept unstimulated orwere st
from the respective cell lysates were further processed as described in A.membrane, in particular in membrane protrusions and membrane ruf-
ﬂes (Fig. 3). This cortical colocalization of IQGAP1 and ezrin is already
evident in unstimulated cells.
3.2. IQGAP1 and ezrin interact directly
Prompted by the above results, in particular the observation that
the degree of co-IP of IQGAP1 and ezrin is not affected signiﬁcantly by
the ectopic expression of GFP–S100P and that both proteins colocalize
to some extent in unstimulated cells at resting Ca2+ levels, i.e. without
activation of S100P (Figs. 2 and 3), we analyzed whether IQGAP1 and
ezrin can interact with one another independent of Ca2+-bound
S100P. Therefore, a co-IP of IQGAP1 and ezrin was carried out in the
presence and absence of elevated Ca2+ levels. Fig. 4 reveals that an efﬁ-
cient co-IP is observed also in the absence of Ca2+, although the relative
amount of co-precipitated ezrin is higher in the presence as compared
to the absence of Ca2+. Thus, it appears that IQGAP1–ezrin complexes
can form independently of active, Ca2+-bound S100P and that S100P
can increase this complex formation in response to Ca2+ elevation. In
line with the colocalization of both proteins in unstimulated HeLa
cells, the efﬁcient co-IP of IQGAP1 and ezrin is not signiﬁcantly affected
by EGF stimulation (Fig. 4). This indicates that a complex consisting of
IQGAP1 and ezrin can form even in resting cells, i.e. probably withoutIQGAP1
Ezrin
2 mM EGTA
PNS - IP C
IQGAP1
Ezrin
EGF stimulated
PNS - IP
resence or absence (2mMEGTA) of Ca2+ and 3mg of protein of a post nuclear supernatant
nal anti-IQGAP1 antibodies (IP) or nonspeciﬁc polyclonal IgGs (control, C). The PNS and the
nd polyclonal anti-ezrin antibodies (1:5000). A (bar graph). The relative amount of ezrin in
unt of IQGAP1. Quantiﬁcation was achieved by densitometry as described in theMaterials
imulated with 50 ng/ml EGF for 5min before cell lysis. Equal amounts of the PNS prepared
2091R.C. Nammalwar et al. / Biochimica et Biophysica Acta 1853 (2015) 2086–2094full activation of the autoinhibited ezrin. However, as colocalization
of the two proteins appears to be restricted to areas of membrane pro-
trusions that usually contain activated ezrin (Fig. 3), it remains possible
that the resting HeLa cells employed in our analysis contain enough ac-
tive, membrane-recruited ezrin that could establish an interaction in
the cell cortex. Future experiments have to reveal to what extent dor-
mant, autoinhibited ezrin can indeed bind IQGAP1.
As such co-IP of IQGAP1 and ezrin had not been reported before, we
explored the S100-independent IQGAP1–ezrin association in more
detail. While co-IP is indicative of an association, it does not show that
the two proteins interact directly. To address the question of direct in-
teraction we performed binding experiments using puriﬁed proteins.
A ﬁrst series of experiments employed the two major protein interac-
tion domains of ezrin to also map a potential IQGAP1 binding site
in the ezrin molecule. N-ERMAD and C-ERMAD were expressed as
His-tagged fusions, puriﬁed and applied to glutathione-Sepharose col-
umns containing either puriﬁed GST-tagged IQGAP1 or GST alone as
control. Bound proteins were then eluted with reduced glutathione to
release the column-bound GST-protein (GST–IQGAP1 or GST) and any
interacting ezrin derivative. While a direct interaction was observed
for N-ERMAD, no interaction of C-ERMAD with immobilized GST–
IQGAP1 could be seen (Fig. 5). The binding was speciﬁc for IQGAP1 as
immobilized GST alone did not show an interaction with N-ERMAD.
Thus, IQGAP1 and ezrin can interact directly and the binding site is lo-
cated in the N-terminal ERM association domain of ezrin. This domain
also harbors the binding sites for different membrane proteins, the
membrane lipid phosphatidylinositol (4,5)-bisphosphate (PIP2) and
S100P (for review see [14]).
Next, we mapped the ezrin binding site on IQGAP1 by employing
in vitro translated IQGAP1 mutant derivatives and immobilized GST–
N-ERMAD. In a ﬁrst set of experiments we could show that N-ERMAD
binds to the N-terminal part of IQGAP1 encompassing the CHD, IR,
WW and IQ domains (Fig. 6). Thus, we next employed IQGAP1mutants
comprising different combinations of these domains and analyzedFT 1 7 1 2 3 4 5
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FT 1 7 1 2 3 4 5
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Fig. 5. IQGAP1 interacts directly with the N-terminal ERM association domain of ezrin.
Representative results of three independent afﬁnity chromatography approacheswith pu-
riﬁed proteins. Equal amounts of (His)6-tagged N-ERMAD (A) or C-ERMAD (B)were load-
ed onto glutathione-Sepharose columns containing immobilized GST–IQGAP1 or, as
exempliﬁed for N-ERMAD, onto columns containing GST alone (C). After several washing
steps, protein complexeswere eluted by applying a buffer containing reduced glutathione.
Eluted fractions were subjected to Western blot analysis using monoclonal anti-(His)6,
anti-IQGAP1 or anti-GST antibodies. The lower part of panel A shows some unspeciﬁc
background not coinciding with protein bands. The double band of His-CERMAD seen in
the ﬂow through in panel B is most likely due to proteolysis.their capability of N-ERMAD binding in the pulldown assay. Fig. 6
shows that all mutant derivatives containing the IQ domain bind to
immobilized N-ERMAD, whereas those lacking the IQ domain did not
interact. Furthermore, a truncated derivative solely encompassing
residues 745–862 and thus the four IQ motifs of the IQ domain also
interacted with N-ERMAD (Fig. 6). Collectively, these binding studies
show that ezrin and IQGAP1 can interact directly with one another
and that the binding sites for this interaction map to the N-ERMAD
and IQ domains, respectively.
The IQ domain of IQGAP1 harbor interaction sites for several other
proteins including calmodulin and S100P [16,12] and it remains to be
determined whether and to what extent these protein interactions
interfere with one another. Using a proteomic approach and the
IQGAP-speciﬁc internal repeat (IR) sequences as a bait, an interaction
of these repeats with the FERM domain of ERM proteins has been
reported recently [19]. However, the mode of interaction appears to
be different from the IQ domain-mediated ezrin binding seen in our
experiments as (1) the repeat-mediated binding is not seen for the
non-activated ezrin and (2) we do not observe an interaction of N-
ERMAD with the IR region of IQGAP1 in our experimental setup
(Fig. 6). We have no experimentally substantiated explanation for
these discrepant ﬁndings concerning the IQGAP1–ezrin interaction
site but think that the different observations might be due to the differ-
ent constructs used.Whereas [19] employed the IR region as an isolated
domain, we used longer domain constructs (Fig. 6) or full-length
IQGAP1 (Fig. 5). Thus, an interaction of N-ERMAD with the IR region
might be masked in, e.g., the IR-WW constructs and therefore escaped
detection in our approach.
3.3. Ezrin depletion affects the IQGAP1 distribution in human epithelial
ECV304 cells
Given the direct interaction of ezrin and IQGAP1 seen in pulldown
and co-IP experiments we nextwanted to analyzewhether this interac-
tion plays a role in determining the cortical localization of the proteins.
IQGAP1 had been shown previously to localize to the submembranous
cytoskeleton of various cells and a recent report could identify the
membrane skeleton protein 4.1R as an interaction partner that is
involved in directing IQGAP1 to the leading edge of human epithelial
ECV304 cells duringwound closuremigration [18]. Because ezrin shares
some homology with protein 4.1R in the N-ERMAD domain, we
also employed these cells to analyzewhether ezrin plays a role in deter-
mining a cortical localization of IQGAP1. Fig. 7A reveals that, similar to
HeLa cells, ECV304 cells also show an enrichment of both, ezrin and
IQGAP1 at or close to the plasma membrane. Next, we depleted the
ECV304 cells of ezrin by employing speciﬁc siRNAs and analyzed the
effect on IQGAP1 distribution. An efﬁcient knockdown of ezrin could
be achieved as revealed byWestern blot as well as immunoﬂuorescence
analysis and this knockdown did not affect the total level of IQGAP1
(Fig. 7B and C). The localization of IQGAP1 in the ezrin knockdown
cells was then analyzed by immunoﬂuorescence microscopy and com-
pared to that of cells transfected with control siRNA. As shown in
Fig. 7C, a signiﬁcant reduction of cortical IQGAP1 staining is observed
in the ezrin-depleted cells indicative of a role of ezrin in establishing
an enrichment of IQGAP1 in the cell cortex of ECV304 cells.
Because cortical colocalization of ezrin and IQGAP1 is already seen
in unstimulated HeLa and ECV304 cells, we believe that full activation
of ezrin by phosphorylation of Thr-567 occurring downstream of
stimulated growth factor receptors is not necessary to establish an
IQGAP1 binding-competent ezrin conformation. Non-phosphorylated
ezrin can bind the plasma membrane lipid PIP2 [23] and thus can
also be targeted to the plasma membrane via lipid binding [24]. Most
likely, such membrane-bound ezrin could in turn recruit IQGAP1 to
submembranous sites via the direct interaction described here. Upon
intracellular Ca2+ elevation, for example in response to growth factor
stimulation, Ca2+-bound S100P could then be directed to the cortical
CHD-IR-WW
CHD-IQ
IQ
IR-WW-IQ
IR-WW
GS
T-
N-
ER
M
AD
GS
T 
al
on
e
Tn
T 
ly
sa
te
100 -
100 -
35 -
65 -
70 -
70 -
25 -
17 -
IQGAP1 N-ter
IQGAP1 full length
100 -
250 -
70 -
130 -
GS
T-
N-
ER
M
AD
GS
T 
al
on
e
GS
T-
N-
ER
M
AD
GS
T 
al
on
e
Tn
T 
ly
sa
te
kDa
Fig. 6.N-ERMAD binds to the IQ domain of IQGAP1. Schematic overviews of full length IQGAP1 and its mutant derivativeswhichwere tested for N-ERMAD binding are represented on the
left hand side. The corresponding results of in-vitro interaction experiments are on the right. [35S]-methionine-labeled full-length IQGAP1 protein as well as the mutants comprising dif-
ferent domains were translated in vitro. Subsequently, they were loaded onto glutathione-Sepharose beads containing immobilized GST–N-ERMAD or GST alone (control) in the absence
of Ca2+. After washing several times, the bound protein complexes as well as the lysate from the respective in vitro expression (TnT lysate) were subjected to SDS-PAGE followed by au-
toradiography. Note that full length IQGAP1 and all themutants containing the IQdomain (including the IQdomain alone) bound toGST–N-ERMAD. Thedouble bands seen in case of CHD–
IQ and IR–WW are most likely the result of some proteolysis occurring during expression or pulldown. Abbreviations used are as follows: CHD, calponin homology domain; IR, internal
repeats; WW, domain with two conserved Trp (W) residues; IQ, IQ domain containing 4 IQ motifs; GRD, GAP related domain; RGCT, Ras-GAP C-terminus.
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IQGAP1 molecules and stabilize an activated ezrin conformation
(Fig. 8). The close apposition of IQGAP1 and ezrin in such complexes
could establish a physical link between membrane-F-actin attachment
sites provided by ezrin and signaling molecules regulating actindynamics such as Cdc42 and Rac1 that are recruited by IQGAP1. As a
consequence, speciﬁc actin modulation can be targeted to membrane–
actin contact sites. Future experiments have to reveal whether such
close proximity indeed exists and also involves downstream effectors
of Cdc42 and Rac1.
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Fig. 7. Ezrin and IQGAP1 colocalize in ECV304 cells and the down regulation of ezrin reduces the cortical localization of IQGAP1. A. Ezrin and IQGAP1 colocalize in ECV304 cells and
are enriched in the cell cortex. After ﬁxation and permeabilization, cells were stained with polyclonal antibodies against human IQGAP1 (green channel) and monoclonal antibodies
against human ezrin (red channel) followed by appropriate ﬂuorescently labeled secondary antibodies. Scale bars, 10 μm. B. Western blot analysis of ECV304 cells transfected with
control or ezrin siRNA. Blots were stained with polyclonal anti-ezrin (1:5000), monoclonal anti-IQGAP1 (1:5000) and anti-α-tubulin (1: 10,000) (loading control) antibodies. Note
that the expression levels of IQGAP1 remain unaffected upon ezrin downregulation. C (left). Representative confocal images of IQGAP1 and ezrin staining in siControl-transfected and
ezrin down-regulated ECV304 cells.White arrowheads denote the co-enrichment of IQGAP1 and ezrin in the cortex of control transfected cells. Note the reduction in cortical IQGAP1 signal
upon ezrin depletion. C (right), Quantiﬁcation of cortical IQGAP1 in control and ezrin depleted cells. n = 30 cells in control as well as ezrin depleted conditions. ***, P b 0.05. Error bars
represent SEM.
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The multidomain protein IQGAP1 is a scaffolding protein in the
submembranous cytoskeleton that has been shown to function in
several signaling pathway by recruiting signaling intermediates
through direct interactions and thereby providing a close proximity
required for efﬁcient signal transduction (for review see [16]).
Signaling-competent molecules assembled by IQGAP1 include Rhoprotein familymembers that act in organizing actin dynamics and inter-
mediates of the MEK/ERK signal transduction pathway. Here we show
that IQGAP1 can also bind an important structural protein of the corti-
cal cytoskeleton, themembrane-F-actin linker ezrin. Thereby regulators
of actin organization such as Cdc42 and Rac1 can be placed in close
proximity to where actin ﬁlaments dock at the plasma membrane en-
abling a tight spatial control of actin dynamics directly at the plasma
membrane.
Ca++
IQGAP1
Ezrin
F-actin
A
B
Fig. 8. Schematic illustration of the IQGAP1/ezrin/S100P complex formations. Non-phosphorylated ezrin that is bound to the plasmamembrane in unstimulated cells via PI(4,5)P2 binding
could recruit IQGAP1 to the cell cortex. Upon an intracellular Ca2+ rise which could result fromgrowth factor stimulation, Ca2+ bound S100P could be directed to such IQGAP1/ezrin com-
plexes. This could result in further recruitment of ezrin and IQGAP1 and/or stabilization of the ezrin–IQGAP1 interaction thereby contributing to the coordinated regulation of cortical cell
dynamics.
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